Benefit of losartan/hydrochlorothiazide-fixed dose combination treatment for isolated morning hypertension: The MAPPY study

Clinical and Experimental Hypertension

Volumn 37, Issue 6, 2015, Pages 473-481

  Kai, Hisashi ^a   Ueda, Tamenobu ^a   Uchiwa, Hiroki ^a   Iwamoto, Yoshiko ^a   Aoki, Yuji ^a   Anegawa, Takahiro ^a   Fukuda, Kenji ^a,b   Fukumoto, Yoshihiro ^a   Imaizumi, Tsutomu ^a,c  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARY S HOSPITAL   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Angiotensin receptor blockers; combination therapy; diuretics; morning hypertension; treatment

Indexed keywords

HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LOSARTAN; URIC ACID; DRUG COMBINATION; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE, LOSARTAN DRUG COMBINATION;

AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; ISOLATED MORNING HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URIC ACID BLOOD LEVEL; BLOOD PRESSURE; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84942192806     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2015.1013118     Document Type: Conference Paper

References (27)

1. Kario K, Ishikawa J, Pickering TG, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006;29:581-7.
2. Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by home "morning" versus "evening" blood pressure values: the Ohasama study. Hypertension 2006;48:737-43.
3. Matsui Y, Eguchi K, Shibasaki S, et al. Morning hypertension assessed by home monitoring is a strong predictor of concentric left ventricular hypertrophy in patients with untreated hypertension. J Clin Hypertens (Greenwich) 2010;12:776-83.
4. Imai Y, Ohkubo T, Tsuji I, et al. Relationships among blood pressures obtained using different measurement methods in the general population of Ohasama, Japan. Hypertens Res 1999;22: 261-72.
5. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population based observation in Ohasama, Japan. J Hypertens 1998;16:971-5.
6. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e loro Associazioni (pamela) study. Circulation 2005;111:1777-83.
7. Ueda T, Kai H, Imaizumi T, on behalf of MAPPY study investigators. Losartan/hydrochlorothiazide combination vs. High dose losartan in patients with morning hypertension - a prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res 2012;35:708-14.
8. Kai H, Kaneyuki M, Shihara M, et al, MAPPY Study Investigators. Reduction in morning blood pressure is a key factor for ameliorating urinary albumin excretion in patients with morning hypertension irrespective of treatment regimen. Circ J 2013;77: 1551-7.
9. Aikawa R, Komuro I, Yamazaki T, et al. Rho family small g proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ Res 1999;84: 458-66.
10. Asayama K, Ohkubo T, Sato A, et al. Proposal of a riskstratification system for the Japanese population based on blood pressure levels: the Ohasama study. Hypertens Res 2008;31: 1315-22.
11. Ogihara T, Kikuchi K, Matsuoka H, et al., Japanese Society of Hypertension Committee. The Japanese Society of Hypertension guidelines for the management of hypertension. Hypertens Res 2009;32:3-107.
12. Shimamoto K, Ando K, Fujita T, et al., on behalf of The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension guidelines for the management of hypertension 2014. Hypertens Res 2014;37:253-392.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1975;13:31-41.
14. Obara T, Ito K, Ohkubo T, et al. Uncontrolled hypertension based on morning and evening home blood pressure measurements from the j-home study. Hypertens Res 2009;32:1072-8.
15. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993;153:598-615.
16. Stergiou GS, Nasothimiou EG. Does dosing antihypertensive drugs at night alter renal or cardiovascular outcome: do we have the evidence? Curr Opin Nephrol Hypertens 2008;17: 464-9.
17. MacKay JH, Arcuri KE, Goldberg AI, et al. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension: a double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996; 156:278-85.
18. Fenton C, Keating GM, Scott LJ. Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension. Drugs 2003;63:2013-26.
19. Yamada Y, Tsuboi K, Hattori T, et al. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension. Hypertens Res 2011; 34:809-16.
20. Chonan K, Hashimoto J, Ohkubo T, et al. Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Clin Exp Hypertens 2002;24:261-75.
21. Elliot HL, Meredith PA. Clinical implications of the trough:peak ratio. Blood Press Monit 1996;1:S47-51.
22. White WB, Mansoor GA, Tendler BE, Anwar YA. Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy. Blood Press Monit 1998; 3:43-51.
23. Eguchi K, Hoshide S, Kabutoya T, et al. Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients? Blood Press Monit 2010;15: 308-11.
24. de la Sierra A, Segura J, Gorostidi M, et al. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res 2010;33:767-71.
25. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999;100:1635-8.
26. Burnier M, Zanchi A. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes. J Hypertens 2006;24:11-25.
27. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002;417:447-52.